There are no products listed under this category.
NMBR
NMBR (neuromedin B receptor, also known as BB1, BB1R and BRS1) is a seven-transmembrane G protein-coupled receptor that binds neuromedin B. It contributes to respiratory rhythm, sneezing, itch and antiviral responses, and belongs to the bombesin receptor group. Browse Assay Genie's current range of NMBR research reagents below, or read on for the biology behind the target.
NMBR is the receptor for neuromedin-B (NMB). Signalling through NMBR helps maintain the basal sigh rate in the pre-Botzinger complex, a cluster of several thousand neurons in the ventrolateral medulla responsible for inspiration. It also contributes to sneezing: exposure to chemical irritants or allergens causes nasal sensory neurons to release NMB, which activates NMBR-expressing neurons in the sneeze-evoking region of the brainstem. These neurons in turn activate the caudal ventral respiratory group, producing the sneezing response. NMBR is also implicated in acute itch, possibly through activation on dorsal root ganglion neurons by the NMB peptide.
The NMBR gene encodes a seven-transmembrane G protein-coupled receptor of the G protein-coupled receptor 1 family, located at the cell membrane. NMB is described as a growth factor and mitogen for gastrointestinal epithelial tissue and for normal and neoplastic lung, and the receptor may play a role in smooth muscle contraction, neuronal responses and the regulation of cell growth. Alternative splicing of the gene results in multiple transcript variants. Mouse and rat orthologs, both named Nmbr, are recognised.
NMBR also acts in immunity and bone biology. It plays a role in the innate immune response to influenza A virus infection by enhancing interferon alpha expression and reducing expression of IL-6. It contributes to CSF1-induced proliferation of osteoclast precursors by positively regulating expression of the CSF1 receptor, CSF1R. Antagonists of this receptor have potential therapeutic use in inhibiting tumour cell growth, and polymorphisms in the gene may be associated with susceptibility to schizophrenia. BB1, BB1R and BRS1 are alternative names, reflecting its place among the bombesin receptors.
NMBR signalling in the pre-Botzinger complex contributes to the maintenance of basal sigh rate during respiratory activity.
NMBR-expressing brainstem neurons mediate sneezing evoked by irritants or allergens, and the receptor contributes to acute itch.
NMBR enhances interferon alpha expression and reduces IL-6 expression in the innate response to influenza A virus infection.
NMBR antagonists may inhibit tumour cell growth, and the receptor supports CSF1R expression in CSF1-driven osteoclast precursor proliferation.
NMBR is the receptor for neuromedin-B. It contributes to basal sigh rate, sneezing, acute itch, the innate response to influenza A virus and CSF1-induced proliferation of osteoclast precursors. It may also influence smooth muscle contraction, neuronal responses and cell growth.
NMBR stands for neuromedin B receptor and is also called BB1, BB1R and BRS1. HGNC places it in the bombesin receptors group. Alternative splicing of the gene produces multiple transcript variants.
Mouse and rat both have an ortholog named Nmbr. NCBI notes that polymorphisms in the human gene may be associated with schizophrenia susceptibility, and that antagonists have potential use in inhibiting tumour cell growth. Check the datasheet of any product for its validated reactivity.
Bombesin receptor family members, ligands and immune and bone signalling partners connected to NMBR biology.
Gene and protein annotations from HGNC, NCBI Gene and UniProt P28336; product specifications from Assay Genie datasheets.
There are no products listed under this category.